Stock PYXS PYXIS ONCOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Pyxis Oncology, Inc.

Equities

PYXS

US7473241013

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
4.34 USD -3.77% Intraday chart for Pyxis Oncology, Inc. -0.91% +141.11%
Mar. 22 H.C. Wainwright Adjusts Price Target on Pyxis Oncology to $7 From $4, Maintains Buy Rating MT
Mar. 21 Health Care Up on Drug Sales Optimism -- Health Care Roundup DJ
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
PYXIS ONCOLOGY, INC. Stock Pyxis Oncology, Inc.
 256M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 109B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 105B
ARGENX SE Stock argenx SE
 22.25B -
BIONTECH SE Stock BioNTech SE
 22.09B -
GENMAB A/S Stock Genmab A/S
 18.68B
  1. Stock Market
  2. Equities
  3. PYXS Stock
  4. Charts Pyxis Oncology, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW